Policy recommendation: latent tuberculosis infection screening and treatment in children in immigration detention

Commun Dis Intell Q Rep. 2015 Dec 31;39(4):E597-8. doi: 10.33321/cdi.2015.39.54.

Authors

Vicki Krause¹; National Tuberculosis Advisory Committee

Collaborators

National Tuberculosis Advisory Committee:
Anthony Allworth, Ral Antic, Ivan Bastian, Philip Clift, Jo Cochrane, Chris Coulter, Paul Douglas, Justin Denholm, Steve Graham, Mark Hurwitz, Vicki Krause, Chris Lowbridge, Rhonda Owen, Richard Stapledon, David Stock, Peter Trevan, Justin Waring

Affiliation

¹ Director, Centre for Disease Control, Department of Health, Northern Territory Government, Ground Floor, Building 4, Royal Darwin Hospital, Tiwi, Northern Territory.

PMID: 26779733
DOI: 10.33321/cdi.2015.39.54

No abstract available

MeSH terms

Adolescent
Antitubercular Agents / therapeutic use*
Australia / epidemiology
Biological Assay
Child
Child, Preschool
Epidemiological Monitoring
Female
Humans
Infant
Interferon-gamma / analysis
Interferon-gamma / biosynthesis
Isoniazid / therapeutic use*
Latent Tuberculosis / diagnosis*
Latent Tuberculosis / drug therapy*
Latent Tuberculosis / epidemiology
Latent Tuberculosis / microbiology
Male
Mass Screening / legislation & jurisprudence*
Mass Screening / organization & administration
Mycobacterium tuberculosis / isolation & purification
Retrospective Studies
Risk Factors
T-Lymphocytes / immunology
T-Lymphocytes / microbiology
Transients and Migrants / statistics & numerical data*
Tuberculin Test

Substances

Antitubercular Agents
Interferon-gamma
Isoniazid